Cmybp-c And Mlc2 As Diagnostic Markers Of Cardiac Injury


The invention relates to markers for acute myocardial infarction (AMI), particularly markers that may be used in the rapid and accurate diagnosis of AMI or reinfarction. A method of diagnosing cardiac injury comprising identifying an elevated concentration of cardiac myosin binding protein C (cMyBP-C) or a fragment thereof or myosin regulatory light chain 2 (MLC2) or a fragment thereof in a sample obtained from a subject.

Download PDF
Document Preview
Document History
  • Publication: Oct 1, 2013
  • Application: May 11, 2010
    US US 201013319484 A
  • Priority: May 11, 2010
    GB GB 2010000935 W
  • Priority: May 11, 2009
    GB GB 0908071 A

Download Citation

Sign in to the Lens